The investment by research and development companies, the new diseases, the knowledge of molecular biology improvement, and computer progress, resulted in a large number of new drugs, treatments and regulations, and these issues demand the execution of expensive, long and unpredictable clinical trials.
The strict regulation of drugs demands clinical trials and safety to deal with the results.
Differentials:
SUSEP number product: 15414.900926/2013-35. 15414.900076/2014-56.